Cite
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings
MLA
Christopher A Darlow, et al. “Assessment of Flomoxef Combined with Amikacin in a Hollow-Fibre Infection Model for the Treatment of Neonatal Sepsis in Low- and Middle-Income Healthcare Settings.” Journal of Antimicrobial Chemotherapy, vol. 77, Sept. 2022, pp. 3349–57. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....35ddf938e05cdfcd1135ed0b48ac2540&authtype=sso&custid=ns315887.
APA
Christopher A Darlow, Laura McEntee, Adam Johnson, Nicola Farrington, Jennifer Unsworth, Ana Jimenez-Valverde, Bhavana Jagota, Ruwanthi Kolamunnage-Dona, Renata M A Da Costa, Sally Ellis, François Franceschi, Mike Sharland, Michael Neely, Laura Piddock, Shampa Das, & William Hope. (2022). Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings. Journal of Antimicrobial Chemotherapy, 77, 3349–3357.
Chicago
Christopher A Darlow, Laura McEntee, Adam Johnson, Nicola Farrington, Jennifer Unsworth, Ana Jimenez-Valverde, Bhavana Jagota, et al. 2022. “Assessment of Flomoxef Combined with Amikacin in a Hollow-Fibre Infection Model for the Treatment of Neonatal Sepsis in Low- and Middle-Income Healthcare Settings.” Journal of Antimicrobial Chemotherapy 77 (September): 3349–57. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....35ddf938e05cdfcd1135ed0b48ac2540&authtype=sso&custid=ns315887.